Hemodialysis unit comprising emergency activation means
    1.
    发明授权
    Hemodialysis unit comprising emergency activation means 有权
    血液透析单元包括紧急激活装置

    公开(公告)号:US08012114B2

    公开(公告)日:2011-09-06

    申请号:US11597539

    申请日:2005-05-14

    Abstract: A haemodialysis device having an emergency activating function is provided. In order to avoid critical drops in blood pressure during a dialysis treatment, the emergency activating function makes it possible for the operating staff to initiate with a single control function a blood pressure measurement and a delivery of substance into the patient's blood in the event of a hypotensive episode and at the same time to have the introduction of these measures by the haemodialyser confirmed clearly through a display having an outward appearance different from that displayed during normal operations. In addition, further automatically introduced process steps can be provided. The emergency activating function speeds up the implementation of the measures to be introduced and, at the same time prevents incorrect operation and makes it possible for the operating staff to attend directly to the patient.

    Abstract translation: 提供具有紧急启动功能的血液透析装置。 为了避免在透析治疗期间血压的临界下降,紧急激活功能使得操作人员能够以单一控制功能启动血压测量和物质在患者血液中的输送 同时,通过具有与正常操作中显示的外观不同的外观的显示器,通过血液透析仪清楚地确认了这些措施的引入。 此外,可以提供进一步的自动引入的处理步骤。 紧急启动功能可加速实施措施的实施,同时防止不正确的操作,使操作人员能够直接到病人身上。

    Device and method for detecting complications during an extracorporeal blood treatment
    2.
    发明授权
    Device and method for detecting complications during an extracorporeal blood treatment 有权
    用于检测体外血液治疗期间并发症的装置和方法

    公开(公告)号:US07674236B2

    公开(公告)日:2010-03-09

    申请号:US11794971

    申请日:2005-10-15

    Abstract: A device and method for detecting complications during an extracorporeal blood treatment are provided. During the dialysis treatment, the dialysance or clearance may be continuously determined at successive points in time based on a measured change in a physical or chemical characteristic quantity of the dialysis liquid, for example, the ion concentration of the dialysis liquid. In the event a significant change in the dialysance or clearance is established, the determination of the recirculation may be effected based on a measured change in a physical or chemical characteristic quantity of the blood. When both a significant change in the determined dialysance as well as in the recirculation occurs, a complication may be assumed with regard to a bad vessel access. Alternatively, a complication may be assumed with regard to the dialyzer. The present invention may allow the continuous monitoring during the dialysis treatment to ensue solely on the basis of the change in the measured dialysate-side characteristic quantities.

    Abstract translation: 提供了一种用于检测体外血液处理期间的并发症的装置和方法。 在透析处理期间,可以基于透析液的物理或化学特性量的测量变化,例如透析液的离子浓度,在连续的时间点连续确定透析或间隙。 如果建立了透析或间隙的重大变化,则可以基于测量的血液的物理或化学特征量的变化来进行再循环的确定。 当发生确定的透析和再循环的显着变化时,可以假设对于不良的血管进入而引起并发症。 或者,可以假设关于透析器的并发症。 本发明可以允许在透析治疗期间的连续监测仅基于所测量的透析液侧特征量的变化而发生。

    Hemodialysis Unit Comprising Emergency Activation Means
    3.
    发明申请
    Hemodialysis Unit Comprising Emergency Activation Means 有权
    血液透析单元包括紧急激活手段

    公开(公告)号:US20070249982A1

    公开(公告)日:2007-10-25

    申请号:US11597539

    申请日:2005-05-14

    Abstract: The invention relates to a haemodialysis -device. In order to avoid critical drops in blood pressure during a dialysis treatment, the invention provides an emergency activating means (58) which makes it possible for the operating staff to initiate with a single control function a blood pressure measurement and a delivery of substance into the patient's blood in the event of a hypotensive episode and at the same time to have the introduction of these measures by the haemodialyser confirmed clearly. In addition, further automatically introduced process steps can be provided. The invention speeds up the implementation of the measures to be introduced, at the same time prevents incorrect operation and makes it possible for the operating staff to attend directly to the patient..

    Abstract translation: 本发明涉及一种血液透析装置。 为了避免在透析治疗期间血压的临界下降,本发明提供了一种紧急激活装置(58),其使得操作人员能够以单一控制功能启动血压测量和将物质输送到 患者的血液在出现低血压事件的同时,由血液透析患者引入这些措施也清楚证实。 此外,可以提供进一步的自动引入的处理步骤。 本发明加快实施措施的实施,同时防止不正确的操作,使操作人员能够直接参与到病人身上。

    Blood treating device
    4.
    发明授权

    公开(公告)号:US09616160B2

    公开(公告)日:2017-04-11

    申请号:US10557823

    申请日:2004-05-13

    Applicant: Pia Daniel

    Inventor: Pia Daniel

    CPC classification number: A61M1/16 A61M2205/505

    Abstract: A blood treatment unit has a blood treatment device which is part of an extracorporeal blood circulatory system. The unit has a control unit and a display and input unit having a touch screen. In order to simplify the operation of the blood treatment unit using the touch screen, the control unit and the display and input unit are suitable for representing various mode means on the touch screen which correspond to the various time modes of the blood treatment. The control unit automatically instigates the beginning of the following time mode at the end of at least one time mode, this being indicated by a change in the representation of the selected mode means on the touch screen. It is especially advantageous to use sensors through whose measured values the control unit identifies the end of one time mode and the beginning of the subsequent time mode.

    Blood Treating Device
    6.
    发明申请
    Blood Treating Device 有权
    血液处理装置

    公开(公告)号:US20070235376A1

    公开(公告)日:2007-10-11

    申请号:US10557823

    申请日:2004-05-13

    Applicant: Pia Daniel

    Inventor: Pia Daniel

    CPC classification number: A61M1/16 A61M2205/505

    Abstract: The invention relates to blood treatment equipment comprising a blood treatment device which is part of an extracorporeal blood circulatory system. The equipment comprises a control unit (30) as well as a display and input unit (32) having a touch screen (33). In order to simplify the operation of the blood treatment equipment using the touch screen, the control unit (30) and the display and input unit (32) are suitable for representing various mode means on the touch screen (33) which correspond to the various time modes of the blood treatment. According to the invention, the control unit automatically instigates the beginning of the following time mode at the end of at least one time mode, this being indicated by a change in the representation of the selected mode means on the touch screen. It is especially advantageous to use sensors (9, 12) through whose measured values the control unit (30) identifies the end of one time mode and the beginning of the subsequent time mode.

    Abstract translation: 本发明涉及血液处理设备,其包括作为体外血液循环系统的一部分的血液处理装置。 该设备包括控制单元(30)以及具有触摸屏(33)的显示和输入单元(32)。 为了简化使用触摸屏的血液处理设备的操作,控制单元(30)和显示和输入单元(32)适于表示触摸屏(33)上的各种模式装置,其对应于各种 血液处理的时间模式。 根据本发明,控制单元在至少一个时间模式结束时自动启动后续时间模式的开始,这由触摸屏上所选模式装置的表示的改变来表示。 特别有利的是,使用传感器(9,12),通过其测量值,控制单元(30)识别一次模式的结束和后续时间模式的开始。

    Device and Method for Detecting Complications During an Extracorporeal Blood Treatment
    8.
    发明申请
    Device and Method for Detecting Complications During an Extracorporeal Blood Treatment 有权
    体外检测并发症的装置和方法

    公开(公告)号:US20080097272A1

    公开(公告)日:2008-04-24

    申请号:US11794971

    申请日:2005-10-15

    Abstract: A device and method for detecting complications during an extracorporeal blood treatment are provided. During the dialysis treatment, the dialysance or clearance may be continuously determined at successive points in time based on a measured change in a physical or chemical characteristic quantity of the dialysis liquid, for example, the ion concentration of the dialysis liquid. In the event a significant change in the dialysance or clearance is established, the determination of the recirculation is may be effected based on a measured change in a physical or chemical characteristic quantity of the blood. When both a significant change in the determined dialysance as well as in the recirculation occurs, a complication is may be assumed with regard to a bad vessel access. Alternatively, a complication may be assumed with regard to the dialyzer. The present invention is may allow the continuous monitoring during the dialysis treatment to ensue solely on the basis of the change in the measured dialysate-side characteristic quantities.

    Abstract translation: 提供了一种用于检测体外血液处理期间的并发症的装置和方法。 在透析处理期间,可以基于透析液的物理或化学特性量的测量变化,例如透析液的离子浓度,在连续的时间点连续确定透析或间隙。 如果建立了透析或间隙的重大变化,则再循环的确定可以基于测量的血液的物理或化学特征量的变化来实现。 当发生确定的透析和再循环的重大变化时,对于不良的血管进入可以假设复杂化。 或者,可以假设关于透析器的并发症。 本发明可以允许在透析治疗期间的连续监测仅仅基于所测量的透析液侧特征量的变化而发生。

Patent Agency Ranking